Depo-Provera, a widely used birth control shot, has been praised for its convenience and affordability. But mounting research and alarming personal stories reveal a darker side to the shot — serious ...

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

The U.S. Food and Drug Administration (FDA) has updated the warning label for the Depo-Provera birth control shot to include information about the risk of meningioma brain tumors. The label update is ...

Depo Provera: The Food and Drug Administration approved a label change on Friday for Pfizer’s birth control injection, Depo-Provera, alerting patients to the risk of meningioma, a tumor that develops ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

The costs of an intracranial meningioma diagnosis can be substantial. Not only can this diagnosis lead to a lifetime of medical bills and other costs, but it can drastically reduce patients’ quality ...

Ellen Relkin, who filed the first case on Tuesday, predicts thousands of lawsuits after a French study in March found the contraceptive Depo-Provera had a 550% higher chance of developing brain tumors ...

"It could be big. I think it could be as big as some of the others we've gotten here," Anapol Weiss shareholder Kila Baldwin said. In March, neurosurgeons and researchers in France published a large ...